Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|July 27, 2022
Memory B-Cell Development After Asymptomatic or Mild Symptomatic SARS-CoV-2 InfectionYu Kato, Nathaniel I Bloom, Peifang Sun, et al.
Vaccines|May 25, 2024
Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman PrimatesJohn W Sanders, Daniel Ewing, Appavu K Sundaram, et al.
Microorganisms|May 28, 2022
Enhanced Immunogenicity of Inactivated Dengue Vaccines by Novel Polysaccharide-Based Adjuvants in MiceShuenn-Jue Wu, Dan Ewing, Appavu K Sundaram, et al.
The American Journal of Tropical Medicine and Hygiene|January 25, 2018
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical TrialJanine R Danko, Tadeusz Kochel, Nimfa Teneza-Mora, et al.
Frontiers in Immunology|December 11, 2023
Antibodies to S2 domain of SARS-CoV-2 spike protein in Moderna mRNA vaccinated subjects sustain antibody-dependent NK cell-mediated cell cytotoxicity against Omicron BA.1Corey A Balinsky, Le Jiang, Vihasi Jani, et al.
The Journal of Infectious Diseases|May 8, 2024
Informing the Need for a SARS-CoV-2 Booster Based on the Immune Responses Among Young Healthy Adults to Variants Circulating in Late 2023Huy C Nguyen, Kerri G Lal, Corey A Balinsky, et al.
Plos Neglected Tropical Diseases|July 23, 2013
Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severityPeifang Sun, Josefina García, Guillermo Comach, et al.
Lancet Regional Health. Americas|November 7, 2024
Clinical and functional assessment of SARS-CoV-2 sequelae among young marines - a panel studyChad K Porter, Charmagne G Beckett, Elizabeth Cooper, et al.
Plos One|April 7, 2022
CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 testMartha Sedegah, Chad Porter, Michael R Hollingdale, et al.
Open Forum Infectious Diseases|March 30, 2026
Informing the Value of "Boosting" Immunocompetent Adults based on Immune Responses Among US Service Members to SARS-CoV-2 Variants in Late 2024Huy C Nguyen, Li Pan, Kerri G Lal, et al.
Pageof 5